Showing results (191-200 of 372) with videos related to

Sort By:
Pageof 38
Oncotarget|February 18, 2016
MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIMNina Stojcheva, Gennadi Schechtmann, Steffen Sass, et al.
Frontiers in Neurology|September 25, 2020
Case Report: A Case of Severe Clinical Deterioration in a Patient With Multiple SclerosisKatharina Breitkopf, Aykut Aytulun, Moritz Förster, et al.
Cancers|February 13, 2021
Integrative Genomic Analyses of Patient-Matched Intracranial and Extracranial Metastases Reveal a Novel Brain-Specific Landscape of Genetic Variants in Driver Genes of Malignant MelanomaRenáta Váraljai, Susanne Horn, Antje Sucker, et al.
Mechanisms of Ageing and Development|April 2, 2014
The hallmarks of fibroblast ageingJulia Tigges, Jean Krutmann, Ellen Fritsche, et al.
Brain Pathology (Zurich, Switzerland)|May 1, 2019
cIMPACT-NOW: a practical summary of diagnostic points from Round 1 updatesDavid N Louis, David W Ellison, Daniel J Brat, et al.
Cell Death Discovery|July 16, 2025
The EIF4EBP1 gene encoding 4EBP1 is transcriptionally upregulated by MYC and linked to shorter survival in medulloblastomaLaura Hruby, Katerina Schaal, Alberto Delaidelli, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 2, 2002
PET imaging drug distribution after intratumoral injection: the case for (124)I-iododeoxyuridine in malignant gliomasUlrich Roelcke, Oliver Hausmann, Adrian Merlo, et al.
Cancer Biology & Therapy|January 23, 2009
Troglitazone-mediated sensitization to TRAIL-induced apoptosis is regulated by proteasome-dependent degradation of FLIP and ERK1/2-dependent phosphorylation of BADKerstin Grund, Rezvan Ahmadi, Fortunata Jung, et al.
Neoplasia (New York, N.Y.)|March 16, 2002
Expression of Bcl-2 family member Bid in normal and malignant tissuesMaryla Krajewska, Juan M Zapata, Ivo Meinhold-Heerlein, et al.
Oncotarget|June 2, 2018
Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma in vitroAbigail Kora Suwala, Katharina Koch, Dayana Herrera Rios, et al.
Pageof 38